Wed. 3 Aug 2022, 5:05pm ET Benzinga Earnings, News
Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.32) by 6.25 percent. This is a 61.9 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $35.47 million which missed the analyst consensus estimate of $35.70 million by 0.65 percent. This is a 15.87 percent increase over sales of $30.61 million the same period last year.